NASDAQ
DataMeds AI, Inc. (MEDS)
♥ 435 Thanks from members
DataMeds AI (MEDS), formerly Wellgistics Health, faces severe going-concern risks and an $19.5M stockholders' deficit despite sequential revenue growth, a recent 1-for-50 reverse split, and upcoming September 2026 app launches with NFL Alumni Health.